 | • レポートコード：TPM-BG076 • 出版社/出版日：Transparency Market Research / 2018年6月 • レポート形態：英文、PDF、213ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、痔瘻治療薬の世界市場について調べ、痔瘻治療薬の世界規模、市場動向、市場環境、治療種類別（非外科手術、外科手術）分析、用途別（括約筋瘻孔、潰瘍性大腸瘻、膀胱括約筋瘻孔、外括約筋瘻孔）分析、最終用途別（病院・外来手術センター、クリニック）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・痔瘻治療薬の世界市場動向 ・痔瘻治療薬の世界市場環境 ・痔瘻治療薬の世界市場規模 ・痔瘻治療薬の世界市場規模：治療種類別（非外科手術、外科手術） ・痔瘻治療薬の世界市場規模：用途別（括約筋瘻孔、潰瘍性大腸瘻、膀胱括約筋瘻孔、外括約筋瘻孔） ・痔瘻治療薬の世界市場規模：最終用途別（病院・外来手術センター、クリニック） ・痔瘻治療薬の世界市場：地域別市場規模・分析 ・痔瘻治療薬の北米市場規模・予測 ・痔瘻治療薬のアメリカ市場規模・予測 ・痔瘻治療薬の中南米市場規模・予測 ・痔瘻治療薬のヨーロッパ市場規模・予測 ・痔瘻治療薬のアジア市場規模・予測 ・痔瘻治療薬の日本市場規模・予測 ・痔瘻治療薬の中国市場規模・予測 ・痔瘻治療薬のインド市場規模・予測 ・痔瘻治療薬の中東市場規模・予測 ・痔瘻治療薬のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Anal Fistula Treatment Market – Overview
Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. Non-surgical methods include drugs as well as fibrin glue injections, adipose stem cell therapy, and collagen paste. This report analyzes the current and future prospects of the global anal fistula treatment market based on treatment type, application, end-user, and region.
This study is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the revenue of the global anal fistula treatment market in the near future. Primary research formed the bulk of the research efforts, with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation, and various international and national databases. The report provides estimated market size in US$ Mn for treatment type, application, end-user, and region for the period of 2018 to 2026.
The report contains an elaborative executive summary, which includes a snapshot providing information on various segments of the market. It also provides information and data analysis of the market with respect to segments based on treatment type, application, end-user, and region. The overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that can influence the global anal fistula treatment market in the current and future scenario. The report also provides Porter’s Five Force Analysis that studies five factors and their impact on the market.
Market share of key players is analyzed to signify the contribution of these players toward the revenue of the market. As such, these factors are likely to help market players in deciding about business strategies and plans for strengthening their position in the global market. Based on region, the market has been analyzed for five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis in these regions for the anal fistula treatment market.
The report also profiles major players in the global anal fistula treatment market in terms of key attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Becton, Dickinson and Company, biolitec AG, Cook Medical, Gem srl, KARL STORZ SE & Co. KG, Medtronic plc, and TiGenix NV. Inorganic growth strategies and business collaborations were the primary strategies adopted by the major players to cement their position in the global anal fistula treatment market.
The global anal fistula treatment market has been segmented as follows:
Global Anal Fistula Treatment Market, by Treatment Type
Non-surgical
Drugs
Others (fibrin glue, adipose stem cell therapy, etc.)
Surgical
Fistulotomy
Bioprosthetic Plugs
Advancement Flap Procedures
Seton Techniques
Others
Global Anal Fistula Treatment Market, by Application
Intersphincteric
Transsphincteric
Suprasphincteric
Extrasphincteric
Others
Global Anal Fistula Treatment Market, by End-user
Hospitals & Ambulatory Surgical Centers
Clinics
Others
Global Anal Fistula Treatment Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
India
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anal Fistula Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anal Fistula Treatment Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Price Comparison Analysis (2017)
5.1.1. By Treatment Type
5.1.2. By Region
5.2.Regulatory Scenario by Region/globally
5.3.Key Mergers & Acquisitions
5.4.Disease Prevalence & Incidence Rate, by Region
5.5.Reimbursement Scenario: Anal Fistula Treatment
5.6.Technological Advancements
6. Global Anal Fistula Treatment Market Analysis and Forecasts, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2016–2026
6.3.1. Non-surgical
6.3.1.1. Drugs
6.3.1.2. Others
6.3.2. Surgical
6.3.2.1. Fistulotomy
6.3.2.2. Bioprosthetic Plugs
6.3.2.3. Seton Techniques
6.3.2.4. Advancement Flap Procedures
6.3.2.5. Others
6.4. Market Attractiveness, by Treatment Type
7. Global Anal Fistula Treatment Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2016–2026
7.3.1. Intersphincteric
7.3.2. Transsphincteric
7.3.3. Suprasphincteric
7.3.4. Extrasphincteric
7.3.5. Others
7.4. Market Attractiveness, by Application
8. Global Anal Fistula Treatment Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Anal Fistula Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Anal Fistula Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2016–2026
10.2.1. Non-surgical
10.2.1.1. Drugs
10.2.1.2. Others
10.2.2. Surgical
10.2.2.1. Fistulotomy
10.2.2.2. Bioprosthetic Plugs
10.2.2.3. Seton Techniques
10.2.2.4. Advancement Flap Procedures
10.2.2.5. Others
10.3. Market Value Forecast, by Application, 2016–2026
10.3.1. Intersphincteric
10.3.2. Transsphincteric
10.3.3. Suprasphincteric
10.3.4. Extrasphincteric
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Anal Fistula Treatment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Treatment Type, 2016–2026
11.2.1. Non-surgical
11.2.1.1. Drugs
11.2.1.2. Others
11.2.2. Surgical
11.2.2.1. Fistulotomy
11.2.2.2. Bioprosthetic Plugs
11.2.2.3. Seton Techniques
11.2.2.4. Advancement Flap Procedures
11.2.2.5. Others
11.3.Market Value Forecast, by Application, 2016–2026
11.3.1. Intersphincteric
11.3.2. Transsphincteric
11.3.3. Suprasphincteric
11.3.4. Extrasphincteric
11.3.5. Others
11.4.Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.2. Clinics
11.4.3. Others
11.5.Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Anal Fistula Treatment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Treatment Type, 2016–2026
12.2.1. Non-surgical
12.2.1.1. Drugs
12.2.1.2. Others
12.2.2. Surgical
12.2.2.1. Fistulotomy
12.2.2.2. Bioprosthetic Plugs
12.2.2.3. Seton Techniques
12.2.2.4. Advancement Flap Procedures
12.2.2.5. Others
12.3.Market Value Forecast, by Application, 2016–2026
12.3.1. Intersphincteric
12.3.2. Transsphincteric
12.3.3. Suprasphincteric
12.3.4. Extrasphincteric
12.3.5. Others
12.4.Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Clinics
12.4.3. Others
12.5.Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Anal Fistula Treatment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Treatment Type, 2016–2026
13.2.1. Non-surgical
13.2.1.1. Drugs
13.2.1.2. Others
13.2.2. Surgical
13.2.2.1. Fistulotomy
13.2.2.2. Bioprosthetic Plugs
13.2.2.3. Seton Techniques
13.2.2.4. Advancement Flap Procedures
13.2.2.5. Others
13.3.Market Value Forecast, by Application, 2016–2026
13.3.1. Intersphincteric
13.3.2. Transsphincteric
13.3.3. Suprasphincteric
13.3.4. Extrasphincteric
13.3.5. Others
13.4.Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Clinics
13.4.3. Others
13.5.Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Anal Fistula Treatment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Treatment Type, 2016–2026
14.2.1. Non-surgical
14.2.1.1. Drugs
14.2.1.2. Others
14.2.2. Surgical
14.2.2.1. Fistulotomy
14.2.2.2. Bioprosthetic Plugs
14.2.2.3. Seton Techniques
14.2.2.4. Advancement Flap Procedures
14.2.2.5. Others
14.3.Market Value Forecast, by Application, 2016–2026
14.3.1. Intersphincteric
14.3.2. Transsphincteric
14.3.3. Suprasphincteric
14.3.4. Extrasphincteric
14.3.5. Others
14.4.Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospitals & Ambulatory Surgical Centers
14.4.2. Clinics
14.4.3. Others
14.5.Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1.Market Footprint Analysis
15.1.1. By Region
15.1.2. By Treatment Type
15.2. Competitive Business Strategies
15.3. Company Profiles
15.3.1. Becton, Dickinson and Company
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Business Overview
15.3.1.3. Product Portfolio
15.3.1.4. Financial Overview
15.3.1.5. SWOT Analysis
15.3.1.6. Strategic Overview
15.3.2. biolitec AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Business Overview
15.3.2.3. Product Portfolio
15.3.2.4. Financial Overview
15.3.2.5. SWOT Analysis
15.3.2.6. Strategic Overview
15.3.3. Cook Medical
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Business Overview
15.3.3.3. Product Portfolio
15.3.3.4. Financial Overview
15.3.3.5. SWOT Analysis
15.3.3.6. Strategic Overview
15.3.4. Gem srl
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Business Overview
15.3.4.3. Product Portfolio
15.3.4.4. Financial Overview
15.3.4.5. SWOT Analysis
15.3.4.6. Strategic Overview
15.3.5. KARL STORZ SE & Co. KG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Business Overview
15.3.5.3. Product Portfolio
15.3.5.4. Financial Overview
15.3.5.5. SWOT Analysis
15.3.5.6. Strategic Overview
15.3.6. Medtronic plc
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
15.3.6. TiGenix NV
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
15.3.6. W. L. Gore & Associates, Inc. (Gore Medical)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Business Overview
15.3.6.3. Product Portfolio
15.3.6.4. Financial Overview
15.3.6.5. SWOT Analysis
15.3.6.6. Strategic Overview
Table 01: Key Mergers/Acquisitions/Collaborations
Table 02: Technological Advancements
Table 03: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 04: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type (Non-surgical), 2016–2026
Table 05: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type (Surgical), 2016–2026
Table 06: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 07: Global Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 08: Global Anal Fistula Treatment Market (US$ Mn) Forecast, by Region, 2016–2026
Table 09: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 10: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 11: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical Treatment, 2016–2026
Table 12: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2016–2026
Table 13: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 14: North America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 17: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical Treatment, 2016–2026
Table 18: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2016–2026
Table 19: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 20: Europe Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 23: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical Treatment, 2016–2026
Table 24: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical Treatment, 2016–2026
Table 25: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 26: Asia Pacific Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 27: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 28: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 29: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical, 2016–2026
Table 30: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical, 2016–2026
Table 31: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 32: Latin America Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 33: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 34: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 35: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Non-surgical, 2016–2026
Table 36: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Surgical, 2016–2026
Table 37: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 38: Middle East & Africa (MEA) Anal Fistula Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 39: Key Player’s Market Footprints, by Region
Table 40: Key Player’s Market Footprints, by Region